{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:43:50Z","timestamp":1791290630925,"version":"4.3.0"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2013,6,7]],"date-time":"2013-06-07T00:00:00Z","timestamp":1370563200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0065489","type":"journal-article","created":{"date-parts":[[2013,6,8]],"date-time":"2013-06-08T15:03:22Z","timestamp":1370703802000},"page":"e65489","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["BAK and NOXA Are Critical Determinants of Mitochondrial Apoptosis Induced by Bortezomib in Mesothelioma"],"prefix":"10.1371","volume":"8","author":[{"given":"Sara","family":"Busacca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex D.","family":"Chacko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astero","family":"Klabatsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Arthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sheaff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vignesh K.","family":"Gunasekharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia J.","family":"Gorski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"El-Tanani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. Courtney","family":"Broaddus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Gaudino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean A.","family":"Fennell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,6,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/ncponc1039","article-title":"Advances in the systemic therapy of malignant pleural mesothelioma","volume":"5","author":"DA Fennell","year":"2008","journal-title":"Nat Clin Pract Oncol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"6881","DOI":"10.1200\/JCO.20005.14.589","article-title":"Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada","volume":"23","author":"JP van Meerbeeck","year":"2005","journal-title":"J Clin Oncol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"NJ Vogelzang","year":"2003","journal-title":"J Clin Oncol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S1470-2045(04)01492-5","article-title":"Defective core-apoptosis signalling in diffuse malignant pleural mesothelioma: opportunities for effective drug development","volume":"5","author":"DA Fennell","year":"2004","journal-title":"Lancet Oncol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00280-007-0500-1","article-title":"Preclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesothelioma","volume":"61","author":"GJ Gordon","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"5942","DOI":"10.1158\/1078-0432.CCR-07-0536","article-title":"Bortezomib inhibits nuclear factor-kappaB dependent survival and has potent in vivo activity in mesothelioma","volume":"13","author":"A Sartore-Bianchi","year":"2007","journal-title":"Clin Cancer Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1097\/JTO.0b013e318260dfb9","article-title":"Phase II clinical trial of first or second-line treatment with bortezomib in patients with malignant pleural mesothelioma","volume":"7","author":"DA Fennell","year":"2012","journal-title":"J Thorac Oncol"},{"key":"ref8","first-page":"755","article-title":"Utility of bortezomib retreatment in relapsed or refractory multiple myeloma patients: a multicenter case series","volume":"6","author":"J Wolf","year":"2008","journal-title":"Clin Adv Hematol Oncol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/jcb.21405","article-title":"Increased expression and altered subunit composition of proteasomes induced by continuous proteasome inhibition establish apoptosis resistance and hyperproliferation of Burkitt lymphoma cells","volume":"103","author":"D Fuchs","year":"2008","journal-title":"J Cell Biochem"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.exphem.2008.04.013","article-title":"Overexpression of the PSMB5 gene contributes to bortezomib resistance in T-lymphoblastic lymphoma\/leukemia cells derived from Jurkat line","volume":"36","author":"S Lu","year":"2008","journal-title":"Exp Hematol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.exphem.2009.04.001","article-title":"Different mutants of PSMB5 confer varying bortezomib resistance in T lymphoblastic lymphoma\/leukemia cells derived from the Jurkat cell line","volume":"37","author":"S Lu","year":"2009","journal-title":"Exp Hematol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1124\/jpet.108.138131","article-title":"Point mutation of the proteasome beta5 subunit gene is an important mechanism of bortezomib resistance in bortezomib-selected variants of Jurkat T cell lymphoblastic lymphoma\/leukemia line","volume":"326","author":"S Lu","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1182\/blood-2007-08-104950","article-title":"Molecular basis of bortezomib resistance: proteasome subunit beta5 (PSMB5) gene mutation and overexpression of PSMB5 protein","volume":"112","author":"R Oerlemans","year":"2008","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1476-4598-6-73","article-title":"The proteasomal and apoptotic phenotype determine bortezomib sensitivity of non-small cell lung cancer cells","volume":"6","author":"J Voortman","year":"2007","journal-title":"Mol Cancer"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1073\/pnas.0807611106","article-title":"ERAD inhibitors integrate ER stress with an epigenetic mechanism to activate BH3-only protein NOXA in cancer cells","volume":"106","author":"Q Wang","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.4161\/cc.8.23.10086","article-title":"Role of ATF4 in regulation of autophagy and resistance to drugs and hypoxia","volume":"8","author":"T Rzymski","year":"2009","journal-title":"Cell Cycle"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/sj.onc.1210744","article-title":"BCL-2 family regulation by the 20S proteasome inhibitor bortezomib","volume":"27","author":"DA Fennell","year":"2008","journal-title":"Oncogene"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/0003-4975(94)90090-6","article-title":"Successful adenovirus-mediated gene transfer in an in vivo model of human malignant mesothelioma","volume":"57","author":"WR Smythe","year":"1994","journal-title":"Ann Thorac Surg"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ijc.2910470219","article-title":"Establishment and characterization of five human malignant mesothelioma cell lines derived from pleural effusions","volume":"47","author":"LS Manning","year":"1991","journal-title":"Int J Cancer"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1126\/science.1081208","article-title":"BAX and BAK regulation of endoplasmic reticulum Ca2+: a control point for apoptosis","volume":"300","author":"L Scorrano","year":"2003","journal-title":"Science"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Swift S, Lorens J, Achacoso P, Nolan GP (2001) Rapid production of retroviruses for efficient gene delivery to mammalian cells using 293T cell-based systems. Curr Protoc Immunol Chapter 10: Unit 10 17C.","DOI":"10.1002\/0471142735.im1017cs31"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"6282","DOI":"10.1158\/0008-5472.CAN-05-0676","article-title":"Proteasome inhibitors trigger NOXA-mediated apoptosis in melanoma and myeloma cells","volume":"65","author":"JZ Qin","year":"2005","journal-title":"Cancer Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1093\/jnci\/djm207","article-title":"Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancer","volume":"99","author":"AM Hosey","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"19488","DOI":"10.1073\/pnas.0708380104","article-title":"Tumor cell-selective regulation of NOXA by c-MYC in response to proteasome inhibition","volume":"104","author":"MA Nikiforov","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref25","first-page":"2505","article-title":"A phase I trial of the novel proteasome inhibitor PS341 in advanced solid tumor malignancies","volume":"8","author":"C Aghajanian","year":"2002","journal-title":"Clin Cancer Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"5025","DOI":"10.1200\/JCO.2006.06.1853","article-title":"Randomized phase II study of bortezomib alone and bortezomib in combination with docetaxel in previously treated advanced non-small-cell lung cancer","volume":"24","author":"MP Fanucchi","year":"2006","journal-title":"J Clin Oncol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.lungcan.2009.07.011","article-title":"A randomized phase II study of bortezomib and pemetrexed, in combination or alone, in patients with previously treated advanced non-small-cell lung cancer","volume":"68","author":"GV Scagliotti","year":"2010","journal-title":"Lung Cancer"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1128\/MCB.00813-09","article-title":"Pseudomonas exotoxin A-mediated apoptosis is Bak dependent and preceded by the degradation of Mcl-1","volume":"30","author":"X Du","year":"2010","journal-title":"Mol Cell Biol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.1038\/sj.onc.1206656","article-title":"The proteasome inhibitor PS-341 overcomes TRAIL resistance in Bax and caspase 9-negative or Bcl-xL overexpressing cells","volume":"22","author":"TR Johnson","year":"2003","journal-title":"Oncogene"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1101\/gad.1304105","article-title":"Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins","volume":"19","author":"SN Willis","year":"2005","journal-title":"Genes Dev"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1080\/02841860500468927","article-title":"Expression of bcl-2 family members in malignant pleural mesothelioma","volume":"45","author":"SL O\u2019Kane","year":"2006","journal-title":"Acta Oncol"},{"key":"ref32","first-page":"3508","article-title":"Apoptosis and expression of apoptosis regulating proteins bcl-2, mcl-1, bcl-X, and bax in malignant mesothelioma","volume":"5","author":"Y Soini","year":"1999","journal-title":"Clin Cancer Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"D Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"6294","DOI":"10.1158\/0008-5472.CAN-05-0686","article-title":"Differential regulation of noxa in normal melanocytes and melanoma cells by proteasome inhibition: therapeutic implications","volume":"65","author":"Y Fernandez","year":"2005","journal-title":"Cancer Res"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Ri M, Iida S, Ishida T, Ito A, Yano H, <etal>et al<\/etal>.. (2008) Bortezomib-induced apoptosis in mature T-cell lymphoma cells partially depends on upregulation of Noxa and functional repression of Mcl-1. Cancer Sci.","DOI":"10.1111\/j.1349-7006.2008.01038.x"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1126\/science.288.5468.1053","article-title":"Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis","volume":"288","author":"E Oda","year":"2000","journal-title":"Science"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1476-4598-7-50","article-title":"Effect of bortezomib on human neuroblastoma: analysis of molecular mechanisms involved in cytotoxicity","volume":"7","author":"V Combaret","year":"2008","journal-title":"Mol Cancer"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ajpath.2010.11.010","article-title":"Proteasome inhibitors induce p53-independent apoptosis in human cancer cells","volume":"178","author":"B Pandit","year":"2011","journal-title":"Am J Pathol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"e29466","DOI":"10.1371\/journal.pone.0029466","article-title":"Estrogen-mediated upregulation of Noxa is associated with cell cycle progression in estrogen receptor-positive breast cancer cells","volume":"6","author":"W Liu","year":"2011","journal-title":"PLoS One"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1158\/0008-5472.CAN-05-3727","article-title":"SV40 oncoproteins enhance asbestos-induced DNA double-strand breaks and abrogate senescence in murine mesothelial cells","volume":"67","author":"JR Pietruska","year":"2007","journal-title":"Cancer Res"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1126\/science.1134042","article-title":"Notch, a universal arbiter of cell fate decisions","volume":"314","author":"M Ehebauer","year":"2006","journal-title":"Science"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1111\/j.1582-4934.2009.00661.x","article-title":"Inhibition of DNA methyltransferase induces G2 cell cycle arrest and apoptosis in human colorectal cancer cells via inhibition of JAK2\/STAT3\/STAT5 signalling","volume":"13","author":"H Xiong","year":"2009","journal-title":"J Cell Mol Med"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/sj.emboj.7600509","article-title":"Myc represses transcription through recruitment of DNA methyltransferase corepressor","volume":"24","author":"C Brenner","year":"2005","journal-title":"EMBO J"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1101\/gad.1067003","article-title":"Genomic targets of the human c-Myc protein","volume":"17","author":"PC Fernandez","year":"2003","journal-title":"Genes Dev"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0092-8674(00)81479-8","article-title":"The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins","volume":"94","author":"SB McMahon","year":"1998","journal-title":"Cell"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Ri M, Iida S, Nakashima T, Miyazaki H, Mori F, <etal>et al<\/etal>.. (2010) Bortezomib-resistant myeloma cell lines: a role for mutated PSMB5 in preventing the accumulation of unfolded proteins and fatal ER stress. Leukemia.","DOI":"10.1038\/leu.2010.137"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/cncr.23224","article-title":"Sensitivity of tumor cells to proteasome inhibitors is associated with expression levels and composition of proteasome subunits","volume":"112","author":"A Busse","year":"2008","journal-title":"Cancer"}],"updated-by":[{"DOI":"10.1371\/annotation\/90879c69-ebc5-40b2-9926-4a00e4f9e055","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2013,12,13]],"date-time":"2013-12-13T00:00:00Z","timestamp":1386892800000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0065489","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T00:38:34Z","timestamp":1563151114000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0065489"}},"subtitle":[],"editor":[{"given":"Andrei L.","family":"Gartel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,6,7]]},"references-count":47,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2013,6,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0065489","relation":{"correction":[{"id-type":"doi","id":"10.1371\/annotation\/90879c69-ebc5-40b2-9926-4a00e4f9e055","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,7]]}}}